Riskpilot← Back to searchSign inGet full accessEira Health AB
ABBankruptOrg 5569878043Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2022
SEK 4,2M
+76% vs 2021
EBITDA margin
7.7%
+2200% vs 2021
Equity ratio
33.9%
Financial strength
Net profit 2022
SEK 273K
+5360% vs 2021
| Revenue | SEK 4,2M | +76% |
| EBITDA | SEK 322K | +2200% |
| Net profit | SEK 273K | +5360% |
| Total assets | SEK 1M | +114% |
| Equity | SEK 349K | +353% |
| Employees | 0 | — |
Legal name
Eira Health AB
Org number
5569878043
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 oktober 2014
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets ska bedriva hälso- och sjukvård inom primär- och specialistvård och angränsande verksamhetsområden inklusive diagnostiska metoder, medicinska konsulttjänster, utbildning, forskning samt utveckling av mjukvara för att optimera diagnostiska metoder inom vården.
Address
Email
ann.fatton@adhddoktorn.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 259 | 1 843 | 2 380 | 4 181 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −83 | 26 | 14 | 322 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −39 | −83 | 26 | 14 | 322 |
| Net financials | — | — | −5 | −9 | −10 |
| Profit before tax | −39 | −83 | 21 | 5 | 312 |
| Tax | −0 | −0 | −0 | −0 | −39 |
| Net profit | −39 | −83 | 21 | 5 | 273 |
| Item | 2019 | 2020 | 2021 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 100 | 137 | 525 | 481 | 1 030 |
| Equity | 39 | 51 | 72 | 77 | 349 |
| Long-term debt | 0 | 18 | 178 | 130 | 80 |
| Short-term debt | 61 | 68 | 275 | 274 | 601 |
| Total debt | 61 | 86 | 453 | 404 | 681 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20192022
Equity ratio
33.9%
This company
38.2%
Market median
+11% vs market
20192022
Return on equity
78.2%
This company
18.4%
Market median
+325% vs market
20192022
Net profit margin
6.5%
This company
8.1%
Market median
-20% vs market
20192022
Asset turnover
4.06×
This company
1.12×
Market median
+262% vs market
20192022
Debt / equity
1.95×
This company
0.62×
Market median
-215% vs market
20192022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-04-01 – 2019-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
RM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eira Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Karin Fatton | Chief Executive Officer | 0 companies |
| Ruth Mabikke Bohlin | Deputy Chief Executive Officer | 0 companies |
| Shahrokh Kimiaei | Deputy Board Member | 0 companies |